WEBINAR: Stem cells use in acute respiratory distress syndrome, a complication of COVID-19
THIS IS A TECH ALLIANCE ASSOCIATION EVENT, FREE FOR ALL ATTENDEES.
Hear from Dr Stewart Washer, Non-Executive Director of Cynata Therapeutics Limited an Australian stem cell and regenerative medicine company that is developing a therapeutic stem cell platform technology, Cymerus™.
Cynata’s MSC Cymerus technology transforms induced pluripotent stem cells (iPSCs) into unlimited doses of MSCs that can be used as cell therapies.
In the webinar listen to Stewart talk about the potential of treating patients with ARDS (an inflammatory process leading to build-up of fluid in the lungs and respiratory failure), with stem cells and the role they play in treating COVID-19 patients.